These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20067463)

  • 1. Expression analysis and study of the KLK15 mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
    Mavridis K; Avgeris M; Koutalellis G; Stravodimos K; Scorilas A
    Cancer Sci; 2010 Mar; 101(3):693-9. PubMed ID: 20067463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantified KLK15 gene expression levels discriminate prostate cancer from benign tumors and constitute a novel independent predictor of disease progression.
    Mavridis K; Stravodimos K; Scorilas A
    Prostate; 2013 Aug; 73(11):1191-201. PubMed ID: 23620432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer.
    Yousef GM; Scorilas A; Jung K; Ashworth LK; Diamandis EP
    J Biol Chem; 2001 Jan; 276(1):53-61. PubMed ID: 11010966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of six novel alternative transcripts of the human kallikrein-related peptidase 15 (KLK15), using 3'RACE and high-throughput sequencing.
    Adamopoulos PG; Koukouzeli FΕ; Kontos CK; Scorilas A
    Gene; 2020 Jul; 749():144708. PubMed ID: 32334022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of kallikrein 15 gene expression in prostate tissue.
    Stephan C; Yousef GM; Scorilas A; Jung K; Jung M; Kristiansen G; Hauptmann S; Bharaj BS; Nakamura T; Loening SA; Diamandis E
    J Urol; 2003 Jan; 169(1):361-4. PubMed ID: 12478190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallikrein-related peptidase 4 gene (KLK4) in prostate tumors: quantitative expression analysis and evaluation of its clinical significance.
    Avgeris M; Stravodimos K; Scorilas A
    Prostate; 2011 Dec; 71(16):1780-9. PubMed ID: 21520157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative analysis of human kallikrein 5 (KLK5) expression in prostate needle biopsies: an independent cancer biomarker.
    Korbakis D; Gregorakis AK; Scorilas A
    Clin Chem; 2009 May; 55(5):904-13. PubMed ID: 19299547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between Prostinogen (KLK15) genetic variants and prostate cancer risk and aggressiveness in Australia and a meta-analysis of GWAS data.
    Batra J; Lose F; O'Mara T; Marquart L; Stephens C; Alexander K; Srinivasan S; Eeles RA; Easton DF; Al Olama AA; Kote-Jarai Z; Guy M; Muir K; Lophatananon A; Rahman AA; Neal DE; Hamdy FC; Donovan JL; Chambers S; Gardiner RA; Aitken J; Yaxley J; Kedda MA; Clements JA; Spurdle AB
    PLoS One; 2011; 6(11):e26527. PubMed ID: 22132073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression analysis of osteopontin mRNA splice variants in prostate cancer and benign prostatic hyperplasia.
    Tilli TM; Thuler LC; Matos AR; Coutinho-Camillo CM; Soares FA; da Silva EA; Neves AF; Goulart LR; Gimba ER
    Exp Mol Pathol; 2012 Feb; 92(1):13-9. PubMed ID: 21963599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLK15 is a prognostic marker for progression-free survival in patients with radical prostatectomy.
    Rabien A; Fritzsche FR; Jung M; Tölle A; Diamandis EP; Miller K; Jung K; Kristiansen G; Stephan C
    Int J Cancer; 2010 Nov; 127(10):2386-94. PubMed ID: 20473923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate.
    Henttu P; Lukkarinen O; Vihko P
    Int J Cancer; 1990 Apr; 45(4):654-60. PubMed ID: 1691151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression profile of human tissue kallikrein 15 provides preliminary insights into its roles in the prostate and testis.
    Filippou PS; Ren AH; Soosaipillai A; Papaioannou MD; Korbakis D; Safar R; Diamandis EP; Conner JR
    Clin Biochem; 2018 Sep; 59():78-85. PubMed ID: 29958881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the human kallikrein gene 15 expression in ovarian cancer.
    Yousef GM; Scorilas A; Katsaros D; Fracchioli S; Iskander L; Borgono C; Rigault de la Longrais IA; Puopolo M; Massobrio M; Diamandis EP
    J Clin Oncol; 2003 Aug; 21(16):3119-26. PubMed ID: 12915603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer.
    Yousef GM; Scorilas A; Magklara A; Memari N; Ponzone R; Sismondi P; Biglia N; Abd Ellatif M; Diamandis EP
    Br J Cancer; 2002 Nov; 87(11):1294-300. PubMed ID: 12439720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intron retention: a common splicing event within the human kallikrein gene family.
    Michael IP; Kurlender L; Memari N; Yousef GM; Du D; Grass L; Stephan C; Jung K; Diamandis EP
    Clin Chem; 2005 Mar; 51(3):506-15. PubMed ID: 15650036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
    Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
    Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
    Soni A; Bansal A; Mishra AK; Batra J; Singh LC; Chakraborty A; Yadav DS; Mohanty NK; Saxena S
    Genet Test Mol Biomarkers; 2012 Aug; 16(8):835-40. PubMed ID: 22731640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of kallikrein-related peptidase 7 is decreased in prostate cancer.
    Zhang CY; Zhu Y; Rui WB; Dai J; Shen ZJ
    Asian J Androl; 2015; 17(1):106-10. PubMed ID: 25219913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens.
    Väänänen RM; Lilja H; Cronin A; Kauko L; Rissanen M; Kauko O; Kekki H; Vidbäck S; Nurmi M; Alanen K; Pettersson K
    Clin Biochem; 2013 May; 46(7-8):670-4. PubMed ID: 23391636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.